These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 3725887)

  • 1. Steady state verapamil tissue distribution in the dog: differing tissue accumulation.
    Schwartz JB; Todd E; Abernethy DR; Mitchell JR
    Pharmacology; 1986; 32(6):307-12. PubMed ID: 3725887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial disposition and cardiac pharmacodynamics of verapamil in the dog.
    Keefe DL; Kates RE
    J Pharmacol Exp Ther; 1982 Jan; 220(1):91-6. PubMed ID: 7053427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological pharmacokinetics and pharmacodynamics of (+/-)-verapamil in female rats.
    Todd EL; Abernethy DR
    Biopharm Drug Dispos; 1987; 8(3):285-97. PubMed ID: 3593905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacology of verapamil. V. Tissue distribution of verapamil and norverapamil in rat and dog.
    Hamann SR; Todd GD; McAllister RG
    Pharmacology; 1983; 27(1):1-8. PubMed ID: 6611645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging alters verapamil elimination and dynamics: single dose and steady-state responses.
    Schwartz JB
    J Pharmacol Exp Ther; 1990 Oct; 255(1):364-73. PubMed ID: 2213568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacology of verapamil. I. Elimination kinetics in dogs and correlation of plasma levels with effect on the eletrocardiogram.
    McAllister RG; Bourne DW; Dittert LW
    J Pharmacol Exp Ther; 1977 Jul; 202(1):38-44. PubMed ID: 874818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verapamil pharmacodynamics and disposition in obese hypertensive patients.
    Abernethy DR; Schwartz JB
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):209-15. PubMed ID: 2452316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of inhalational anesthetics on verapamil pharmacokinetics in dogs.
    Chelly JE; Hysing ES; Abernethy DR; Doursout MF; Merin RG
    Anesthesiology; 1986 Sep; 65(3):266-71. PubMed ID: 3752571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of beta-adrenergic blockade on the cardiovascular response to diltiazem or verapamil in dogs.
    Sullivan KB; Kapur PA
    Anesth Analg; 1986 Nov; 65(11):1099-106. PubMed ID: 3021022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrasting effects of verapamil and nifedipine on pH of ischemic myocardium in the dog.
    Ro YM; Markle DR; Goldstein SR; Speir E; Greene R; Steadman K; Aamodt R; Epstein SE; Patterson RE
    J Pharmacol Exp Ther; 1989 Feb; 248(2):654-60. PubMed ID: 2918474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects of (R)- and (S)-verapamil and racemic verapamil in humans: a placebo-controlled study.
    Busse D; Templin S; Mikus G; Schwab M; Hofmann U; Eichelbaum M; Kivistö KT
    Eur J Clin Pharmacol; 2006 Aug; 62(8):613-9. PubMed ID: 16823584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of verapamil on electrophysiologic properties of blood superfused cardiac Purkinje fibers.
    Danilo P; Hordof AJ; Reder RF; Rosen MR
    J Pharmacol Exp Ther; 1980 May; 213(2):222-7. PubMed ID: 7365685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of verapamil on the arrhythmogenic action of acetylstrophanthidin.
    Babich M; Hamann SR; McAllister RG; Pratap Reddy C; Piascik MT
    Pharmacology; 1984; 29(4):224-32. PubMed ID: 6494234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verapamil and the heart: Pharmacological and Therapeutic Considerations.
    DPhil BN
    N Z Med J; 1975 Nov; 82(552):339-43. PubMed ID: 1061888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic and pharmacokinetic interactions between lidocaine and verapamil.
    Chelly JE; Hill DC; Abernethy DR; Dlewati A; Doursout MF; Merin RG
    J Pharmacol Exp Ther; 1987 Oct; 243(1):211-6. PubMed ID: 3668853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bupivacaine accentuates the cardiovascular depressant effects of verapamil in conscious dogs.
    Edouard A; Froidevaux R; Berdeaux A; Ahmad R; Samii K; Noviant Y
    Eur J Anaesthesiol; 1987 Jul; 4(4):249-59. PubMed ID: 3653084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effects of slow-release verapamil in relation to plasma concentration in aged hypertensives. A study with continuous monitoring of arterial pressure and electrocardiogram].
    Canonico V; Bonaduce D; De Caprio L; Nicolino A; Forgione L; Petretta M; Rengo F
    G Ital Cardiol; 1990 Oct; 20(10):924-32. PubMed ID: 2090531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dantrolene and verapamil on atrioventricular conduction and cardiovascular performance in dogs.
    Lynch C; Durbin CG; Fisher NA; Veselis RA; Althaus JS
    Anesth Analg; 1986 Mar; 65(3):252-8. PubMed ID: 3954091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and dynamics of (+/-)-verapamil in lean and obese Zucker rats.
    Todd EL; Abernethy DR
    J Pharmacol Exp Ther; 1986 Aug; 238(2):642-7. PubMed ID: 3735134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LV oxygen consumption and pressure-volume area: role of norepinephrine and verapamil.
    Chung N; Wu X; Ritman EL
    Am J Physiol; 1991 Jul; 261(1 Pt 2):H77-82. PubMed ID: 1858933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.